Regeneron Pharmaceuticals (REGN)
Free Cash Flow Growth
-8.39%
TTM · Period ending:
REGN Free Cash Flow Growth
Year-over-year change vs the same period a year earlier
Latest reported-8.39%period ending
Latest reported-8.39%period ending
REGN TTM Free Cash Flow YoY % (-96.32% → -8.39%)
Year-over-year change
High-resolution chart · PNG
REGN free cash flow growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | Free Cash Flow Growth |
|---|---|
| -18.1467% | |
| 8.3316% | |
| -76.4359% | |
| 27.2813% | |
| -33.2921% | |
| -62.6171% | |
| -47.7273% | |
| -627.2727% | |
| -114.8936% | |
| -101.1494% | |
| -60.9756% | |
| 61.4035% | |
| 44.0476% | |
| 59.3458% | |
| 71.6263% | |
| 60.4167% | |
| 49.0909% | |
| 20.4461% | |
| -34.4186% | |
| 9.434% | |
| -23.5955% | |
| -37.2449% | |
| 21.5328% | |
| 5.3571% | |
| 21.9298% | |
| 58.5624% | |
| 32.0099% | |
| -262.3188% | |
| -28.0899% | |
| -104.7619% | |
| -108.8083% | |
| 131.6514% | |
| -96.3235% |